Literature detail

Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants.

Kayla M Peck1 Trevor Scobey2 Jesica Swanstrom2 Kara L Jensen2 Christina L Burch1 Ralph S Baric3,4 Mark T Heise5,4
Affiliations 5 institutions
  1. Department of Biology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
  2. Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
  3. Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA [email protected] [email protected].
  4. Department of Microbiology and Immunology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
  5. Department of Genetics, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA [email protected] [email protected].
PMID 28747502 2017 J Virol eng epublish
PubMed DOI Browse context

Article

Publication summary

Middle East respiratory syndrome coronavirus (MERS-CoV) utilizes dipeptidyl peptidase 4 (DPP4) as an entry receptor. While bat, camel, and human DPP4 support MERS-CoV infection, several DPP4 orthologs, including mouse, ferret, hamster, and guinea pig DPP4, do not. Previous work revealed that glycosylation of mouse DPP4 plays a role in blocking MERS-CoV infection. Here, we tested whether glycosylation also acts as a determinant of permissivity for ferret, hamster, and guinea pig DPP4. We found that, while glycosylation plays an important role in these orthologs, additional sequence and structural determinants impact their ability to act as functional receptors for MERS-CoV. These results provide insight into DPP4 species-specific differences impacting MERS-CoV host range and better inform our understanding of virus-receptor interactions associated with disease emergence and host susceptibility.<b>IMPORTANCE</b> MERS-CoV is a recently emerged zoonotic virus that is still circulating in the human population with an ∼35% mortality rate. With no available vaccines or therapeutics, the study of MERS-CoV pathogenesis is crucial for its control and prevention. However, <i>in vivo</i> studies are limited because MERS-CoV cannot infect wild-type mice due to incompatibilities between the virus spike and the mouse host cell receptor, mouse DPP4 (mDPP4). Specifically, mDPP4 has a nonconserved glycosylation site that acts as a barrier to MERS-CoV infection. Thus, one mouse model strategy has been to modify the mouse genome to remove this glycosylation site. Here, we investigated whether glycosylation acts as a barrier to infection for other nonpermissive small-animal species, namely, ferret, guinea pig, and hamster. Understanding the virus-receptor interactions for these DPP4 orthologs will help in the development of additional animal models while also revealing species-specific differences impacting MERS-CoV host range.

animal models DPP4 glycosylation host range host range expansion MERS-coronavirus orthologs Virus Attachment Amino Acid Sequence Animals Cell Line Chlorocebus aethiops Coronavirus Infections Cricetinae Dipeptidyl Peptidase 4 Ferrets Glycosylation Guinea Pigs

Structured evidence records

Evidence records

3 total
1 records
Extraction confidence 0.95
Key finding

Bat, camel, and human DPP4 are functional receptors allowing MERS-CoV entry in cell culture, whereas ferret, hamster, guinea pig, and mouse DPP4 block infection due to glycosylation and other structural determinants.

Virus
Location
Not specified
Supporting text

Bat, camel, and human DPP4 support MERS-CoV infection, whereas several DPP4 orthologs, including mouse, ferret, hamster, and guinea pig DPP4, do not.

Method
cell-entry assay; receptor usage assay
Experimental system
in vitro cell culture
1 records
Extraction confidence 0.95
Key finding

Glycosylation and sequence differences in DPP4 orthologs determine MERS-CoV receptor compatibility, influencing host range and species adaptation.

Virus
Host
Not specified
Location
Not specified
Supporting text

Middle East respiratory syndrome coronavirus (MERS-CoV) utilizes dipeptidyl peptidase 4 (DPP4) as an entry receptor. While bat, camel, and human DPP4 support infection, several DPP4 orthologs (mouse, ferret, hamster, guinea pig) do not, due to glycosylation differences and other sequence and structural determinants that affect functional receptor activity.

Genes or proteins
spike; DPP4
Receptors
DPP4
Mechanism types
receptor_binding; host_range_determination; cell_entry
1 records
Extraction confidence 1.00
Key finding

MERS-CoV binds and enters cells via DPP4, but only bat, camel, and human DPP4 orthologs act as functional receptors; glycosylation and other structural features restrict entry via mouse, ferret, hamster, and guinea pig DPP4.

Virus
Location
Not specified
Supporting text

Middle East respiratory syndrome coronavirus (MERS-CoV) utilizes dipeptidyl peptidase 4 (DPP4) as an entry receptor. While bat, camel, and human DPP4 support MERS-CoV infection, several DPP4 orthologs, including mouse, ferret, hamster, and guinea pig DPP4, do not. Glycosylation and structural determinants impact their ability to act as functional receptors for MERS-CoV.

Method
infection assays; sequence and structural analysis
Receptors
Dipeptidyl peptidase 4 (DPP4)
Host factors
glycosylation